Purchase Order 75F40118P10120
Award Date 5/1/18
Potential Completion Date 4/30/19
Potential Value $285K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denver, CO 80225, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $114,681.00 contract is for the delivery of a MiSeq System, a high-throughput next-generation DNA sequencing platform used to support life science research, applied markets, and molecular diagnostics. This award does not have a set-aside designation. Illumina has a history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents, to provide a MiSEQ SYSTEM. The $152,792.00 contract has no set-aside designation. Illumina has previously been awarded prime contracts by other federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans...
- This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...
- The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of a next generation sequencer. The contract has a potential value of $100,980.00 and a completion date of August 28, 2020. Illumina has provided similar sequencing systems and consumables to support genomic research and diagnostics across various federal agencies such as the National...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
- The Department of Health and Human Services' National Institutes of Health awarded a $4,570.01 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents, for the provision of Illumina MiSeq sequencing kits. The contract has no set-aside designation and was awarded on July 28, 2017, with a completion date of August 7, 2017. Illumina has a history of providing sequencing instruments, consumables, and services to support genomic...
- The Department of Health and Human Services Food and Drug Administration awarded a $457,531.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of an ILLUMINA NEXTSEQ 2000 SEQUENCING SYSTEM, plus a preventative maintenance agreement, to be performed in Silver Spring, Maryland. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems and related...